Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. (Q52973447)
Jump to navigation
Jump to search
scientific article published on 22 January 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. |
scientific article published on 22 January 2015 |
Statements
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. (English)
William M Sikov
Eric S Winer
22 January 2015
169
3
352-355